Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 246

    1.

    Irbesartan has no short-term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i-RESPOND).

    Parhofer KG, Birkeland KI, Defronzo R, Del Prato S, Bhaumik A, Ptaszynska A.

    Int J Clin Pract. 2009 Nov 19. [Epub ahead of print]PMID: 19929980 [PubMed - as supplied by publisher]

    2.

    Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes.

    Bianchi C, Miccoli R, Daniele G, Penno G, Del Prato S.

    Diabetes Care. 2009 Nov;32 Suppl 2:S342-8. No abstract available. PMID: 19875578 [PubMed - in process]Related articles

    3.

    Changing the treatment paradigm for type 2 diabetes.

    Del Prato S, Penno G, Miccoli R.

    Diabetes Care. 2009 Nov;32 Suppl 2:S217-22. No abstract available. PMID: 19875555 [PubMed - in process]Related articles

    4.

    How do we define cure of diabetes?

    Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, McLaughlin S, Phillips GL 2nd, Robertson RP, Rubino F, Kahn R, Kirkman MS.

    Diabetes Care. 2009 Nov;32(11):2133-5. No abstract available. PMID: 19875608 [PubMed - in process]Related articles

    5.

    G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: The role of type 2 diabetes and fatty acids.

    Del Guerra S, Bugliani M, D'Aleo V, Del Prato S, Boggi U, Mosca F, Filipponi F, Lupi R.

    Nutr Metab Cardiovasc Dis. 2009 Sep 14. [Epub ahead of print]PMID: 19758793 [PubMed - as supplied by publisher]Related articles

    6.

    Continuous subcutaneous insulin infusion and multiple dose insulin injections in Type 1 diabetic pregnant women: a case-control study.

    Volpe L, Pancani F, Aragona M, Lencioni C, Battini L, Ghio A, Resi V, Bertolotto A, Del Prato S, Di Cianni G.

    Gynecol Endocrinol. 2009 Aug 31:1-4. [Epub ahead of print]PMID: 19728190 [PubMed - as supplied by publisher]Related articles

    7.

    Soluble CD40 ligand levels in essential hypertensive men: evidence of a possible role of insulin resistance.

    Penno G, Pucci L, Dell'Omo G, Lucchesi D, Miccoli R, Del Prato S, Solini A, Pedrinelli R.

    Am J Hypertens. 2009 Sep;22(9):1007-13. Epub 2009 Jul 9.PMID: 19590499 [PubMed - in process]Related articles

    8.

    Modulation of palmitic acid-induced cell death by ergothioneine: evidence of an anti-inflammatory action.

    Laurenza I, Colognato R, Migliore L, Del Prato S, Benzi L.

    Biofactors. 2008;33(4):237-47.PMID: 19509460 [PubMed - indexed for MEDLINE]Related articles

    9.

    The non-peptidyl low molecular weight radical scavenger IAC protects human pancreatic islets from lipotoxicity.

    D'Aleo V, Del Guerra S, Martano M, Bonamassa B, Canistro D, Soleti A, Valgimigli L, Paolini M, Filipponi F, Boggi U, Del Prato S, Lupi R.

    Mol Cell Endocrinol. 2009 Oct 15;309(1-2):63-6. Epub 2009 May 27.PMID: 19481137 [PubMed - indexed for MEDLINE]Related articles

    10.

    Megatrials in type 2 diabetes. From excitement to frustration?

    Del Prato S.

    Diabetologia. 2009 Jul;52(7):1219-26. Epub 2009 Apr 17. Review.PMID: 19373446 [PubMed - indexed for MEDLINE]Related articles

    11.

    Genes, diabetes and cardiovascular risk prediction.

    Del Prato S.

    Nat Rev Endocrinol. 2009 Apr;5(4):192-3.PMID: 19352316 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prognostic implications of diabetes phenotyping: new concepts for an old disease.

    Daniele G, Bianchi C, Di Cianni G, Del Prato S, Miccoli R.

    Intern Emerg Med. 2009 Aug;4(4):325-9. Epub 2009 Mar 14. No abstract available. PMID: 19288180 [PubMed - indexed for MEDLINE]Related articles

    13.

    Beneficial effect of the nonpeptidyl low molecular weight radical scavenger IAC on cultured human islet function.

    Mancarella R, Del Guerra S, Masini M, Bugliani M, Valgimigli L, Pedulli GF, Paolini M, Canistro D, Armando A, Soleti A, Filipponi F, Mosca F, Boggi U, Del Prato S, Marchetti P, Lupi R.

    Cell Transplant. 2008;17(10-11):1271-6.PMID: 19181220 [PubMed - indexed for MEDLINE]Related articles

    14.

    Lack of association between TGF-beta-1 genotypes and microalbuminuria in essential hypertensive men.

    Dell'Omo G, Penno G, Pucci L, Lucchesi D, Del Prato S, Pedrinelli R.

    Nephrol Dial Transplant. 2009 Jun;24(6):1864-9. Epub 2009 Jan 28.PMID: 19176688 [PubMed - indexed for MEDLINE]Related articles

    15.

    Dysglycaemia in non-diabetic hypertensive patients: comparison of the impact of two different classifications of impaired fasting glucose on the cardiovascular risk profile.

    Dell'Omo G, Penno G, Del Prato S, Mariani M, Pedrinelli R.

    J Hum Hypertens. 2009 May;23(5):332-8. Epub 2008 Dec 11.PMID: 19078990 [PubMed - indexed for MEDLINE]Related articles

    16.

    The metabolic syndrome is related to albuminuria in Type 2 diabetes.

    Bianchi C, Penno G, Daniele G, Russo E, Giovannitti MG, Del Prato S, Miccoli R.

    Diabet Med. 2008 Dec;25(12):1412-8.PMID: 19046239 [PubMed - indexed for MEDLINE]Related articles

    17.

    Serum gamma-glutamyltransferase is not associated to peripheral arterial disease in type 2 diabetic patients: Cross-sectional findings.

    Bianchi C, Penno G, Del Prato S, Miccoli R.

    Atherosclerosis. 2009 Mar;203(1):49-50. Epub 2008 Jul 15. No abstract available. PMID: 18715564 [PubMed - indexed for MEDLINE]Related articles

    18.

    Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes.

    Bolli GB, Songini M, Trovati M, Del Prato S, Ghirlanda G, Cordera R, Trevisan R, Riccardi G, Noacco C.

    Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):571-9. Epub 2008 Aug 3.PMID: 18676131 [PubMed - in process]Related articles

    19.

    Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences.

    Lupi R, Del Prato S.

    Diabetes Metab. 2008 Feb;34 Suppl 2:S56-64. Review.PMID: 18640587 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Beta-cell failure in type 2 diabetes mellitus.

    Lencioni C, Lupi R, Del Prato S.

    Curr Diab Rep. 2008 Jun;8(3):179-84. Review.PMID: 18625113 [PubMed - indexed for MEDLINE]Related articles

    21.

    Peripheral wave reflection and endothelial function in untreated essential hypertensive patients with and without the metabolic syndrome.

    Plantinga Y, Ghiadoni L, Magagna A, Giannarelli C, Penno G, Pucci L, Taddei S, Del Prato S, Salvetti A.

    J Hypertens. 2008 Jun;26(6):1216-22.PMID: 18475160 [PubMed - indexed for MEDLINE]Related articles

    22.

    Early subclinical atherosclerosis in women with previous gestational diabetes mellitus.

    Volpe L, Cuccuru I, Lencioni C, Napoli V, Ghio A, Fotino C, Bertolotto A, Penno G, Benzi L, Del Prato S, Di Cianni G.

    Diabetes Care. 2008 May;31(5):e32. No abstract available. PMID: 18445712 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial.

    Del Prato S, Blonde L, Martinez L, Göke B, Woo V, Millward A, Gomis R, Canovatchel B, Strack T, Lawrence D, Freemantle N; EXPERIENCE Trial Team.

    Diabet Med. 2008 Jun;25(6):662-70. Epub 2008 Apr 23.PMID: 18435781 [PubMed - indexed for MEDLINE]Related articles

    24.

    In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.

    Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A.

    Diabet Med. 2008 Mar;25(3):326-32.PMID: 18307459 [PubMed - indexed for MEDLINE]Related articles

    25.

    Primary prevention of cardiovascular disease in people with dysglycemia.

    Bianchi C, Miccoli R, Penno G, Del Prato S.

    Diabetes Care. 2008 Feb;31 Suppl 2:S208-14. Review.PMID: 18227487 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Optimizing management of metabolic syndrome to reduce risk: focus on life-style.

    Bianchi C, Penno G, Daniele G, Benzi L, Del Prato S, Miccoli R.

    Intern Emerg Med. 2008 Jun;3(2):87-98. Epub 2008 Feb 13. Review.PMID: 18270793 [PubMed - indexed for MEDLINE]Related articles

    27.

    Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion.

    Ling C, Del Guerra S, Lupi R, Rönn T, Granhall C, Luthman H, Masiello P, Marchetti P, Groop L, Del Prato S.

    Diabetologia. 2008 Apr;51(4):615-22. Epub 2008 Feb 13.PMID: 18270681 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Effects of exendin-4 on islets from type 2 diabetes patients.

    Lupi R, Mancarella R, Del Guerra S, Bugliani M, Del Prato S, Boggi U, Mosca F, Filipponi F, Marchetti P.

    Diabetes Obes Metab. 2008 Jun;10(6):515-9. Epub 2008 Jan 14.PMID: 18201204 [PubMed - indexed for MEDLINE]Related articles

    29.

    Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus.

    Ghiadoni L, Penno G, Giannarelli C, Plantinga Y, Bernardini M, Pucci L, Miccoli R, Taddei S, Salvetti A, Del Prato S.

    Hypertension. 2008 Feb;51(2):440-5. Epub 2007 Dec 24.PMID: 18158340 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Recommendations from the Global Partnership for Effective Diabetes Management.

    Del Prato S, Felton AM, Munro N, Nesto R, Zimmet P, Zinman B; Global Partnership for Effective Diabetes Management.

    Int J Clin Pract Suppl. 2007 Dec;(157):47-57.PMID: 18087796 [PubMed]Related articles

    31.

    Gestational diabetes, inflammation, and late vascular disease.

    Volpe L, Di Cianni G, Lencioni C, Cuccuru I, Benzi L, Del Prato S.

    J Endocrinol Invest. 2007 Nov;30(10):873-9. Review.PMID: 18075292 [PubMed - indexed for MEDLINE]Related articles

    32.

    Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database.

    Bonora E, Capaldo B, Perin PC, Del Prato S, De Mattia G, Frittitta L, Frontoni S, Leonetti F, Luzi L, Marchesini G, Marini MA, Natali A, Paolisso G, Piatti PM, Pujia A, Solini A, Vettor R, Bonadonna RC; Group of Italian Scientists of Insulin Resistance (GISIR).

    Nutr Metab Cardiovasc Dis. 2008 Nov;18(9):624-31. Epub 2007 Dec 3.PMID: 18060751 [PubMed - indexed for MEDLINE]Related articles

    33.

    We have the evidence, we need to act to improve diabetes care.

    Del Prato S, Horton E, Nesto R; Global Partnership for Effective Diabetes Management.

    Int J Clin Pract Suppl. 2007 Dec;(157):9-15. Review.PMID: 17991186 [PubMed - indexed for MEDLINE]Related articles

    34.

    A call to action--the UN Resolution on diabetes.

    Del Prato S.

    Int J Clin Pract Suppl. 2007 Dec;(157):1-4. No abstract available. PMID: 17991184 [PubMed - indexed for MEDLINE]Related articles

    35.

    Doxazosin in metabolically complicated hypertension.

    Dell'Omo G, Penno G, Del Prato S, Pedrinelli R.

    Expert Rev Cardiovasc Ther. 2007 Nov;5(6):1027-35. Review.PMID: 18035918 [PubMed - indexed for MEDLINE]Related articles

    36.

    Pharmacological intervention in prediabetes: considering the risks and benefits.

    Del Prato S, Bianchi C, Miccoli R, Penno G.

    Diabetes Obes Metab. 2007 Sep;9 Suppl 1:17-22. Review.PMID: 17877543 [PubMed - indexed for MEDLINE]Related articles

    37.

    beta-cell function and anti-diabetic pharmacotherapy.

    Del Prato S, Bianchi C, Marchetti P.

    Diabetes Metab Res Rev. 2007 Oct;23(7):518-27. Review.PMID: 17883249 [PubMed - indexed for MEDLINE]Related articles

    38.

    Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management.

    Crepaldi G, Carruba M, Comaschi M, Del Prato S, Frajese G, Paolisso G.

    J Endocrinol Invest. 2007 Jul-Aug;30(7):610-4. Review.PMID: 17848846 [PubMed - indexed for MEDLINE]Related articles

    39.

    Dipeptidyl peptidase 4 inhibition and vildagliptin therapy for type 2 diabetes.

    Del Prato S.

    Int J Clin Pract Suppl. 2007 Aug;(154):38-48. Review.PMID: 17593276 [PubMed - indexed for MEDLINE]Related articles

    40.

    Type 2 diabetes mellitus: focus on new treatments and special populations.

    Del Prato S.

    Int J Clin Pract Suppl. 2007 Aug;(154):1-2. Review. No abstract available. Erratum in: Int J Clin Pract Suppl. 2007 Oct;61(10):1776. PMID: 17593271 [PubMed - indexed for MEDLINE]Related articles

    41.

    Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.

    Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, Sjögren M, Ling C, Eriksson KF, Lethagen AL, Mancarella R, Berglund G, Tuomi T, Nilsson P, Del Prato S, Groop L.

    J Clin Invest. 2007 Aug;117(8):2155-63.PMID: 17671651 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    High insulin levels impair intracellular receptor trafficking in human cultured myoblasts.

    Bertacca A, Ciccarone A, Cecchetti P, Vianello B, Laurenza I, Del Prato S, Benzi L.

    Diabetes Res Clin Pract. 2007 Dec;78(3):316-23. Epub 2007 Jul 17.PMID: 17644209 [PubMed - indexed for MEDLINE]Related articles

    43.

    Early impairment of left ventricular function in hypercholesterolemia and its reversibility after short term treatment with rosuvastatin A preliminary echocardiographic study.

    Talini E, Di Bello V, Bianchi C, Palagi C, Delle Donne MG, Penno G, Nardi C, Canale ML, Del Prato S, Mariani M, Miccoli R.

    Atherosclerosis. 2008 Mar;197(1):346-54. Epub 2007 Jul 13.PMID: 17631295 [PubMed - indexed for MEDLINE]Related articles

    44.

    Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger.

    Lupi R, Del Guerra S, Mancarella R, Novelli M, Valgimigli L, Pedulli GF, Paolini M, Soleti A, Filipponi F, Mosca F, Boggi U, Del Prato S, Masiello P, Marchetti P.

    Diabetes Metab. 2007 Nov;33(5):340-5. Epub 2007 Jul 9.PMID: 17616474 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Glucose tolerance is negatively associated with circulating progenitor cell levels.

    Fadini GP, Pucci L, Vanacore R, Baesso I, Penno G, Balbarini A, Di Stefano R, Miccoli R, de Kreutzenberg S, Coracina A, Tiengo A, Agostini C, Del Prato S, Avogaro A.

    Diabetologia. 2007 Oct;50(10):2156-63. Epub 2007 Jun 20.PMID: 17579827 [PubMed - indexed for MEDLINE]Related articles

    46.

    Lack of association between endothelial nitric oxide synthase gene polymorphisms, microalbuminuria and endothelial dysfunction in hypertensive men.

    Dell'Omo G, Penno G, Pucci L, Fotino C, Lucchesi D, Del Prato S, Pedrinelli R.

    J Hypertens. 2007 Jul;25(7):1389-95.PMID: 17563560 [PubMed - indexed for MEDLINE]Related articles

    47.

    Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes.

    Bianchi C, Penno G, Pancani F, Civitelli A, Piaggesi A, Caricato F, Pellegrini G, Del Prato S, Miccoli R.

    Diabetes Res Clin Pract. 2007 Nov;78(2):246-53. Epub 2007 May 10.PMID: 17498833 [PubMed - indexed for MEDLINE]Related articles

    48.

    Treating the metabolic syndrome.

    Bianchi C, Penno G, Romero F, Del Prato S, Miccoli R.

    Expert Rev Cardiovasc Ther. 2007 May;5(3):491-506. Review.PMID: 17489673 [PubMed - indexed for MEDLINE]Related articles

    49.

    Correspondence between the International Diabetes Federation criteria for metabolic syndrome and insulin resistance in a cohort of Italian nondiabetic Caucasians: the GISIR database.

    Sesti G, Capaldo B, Cavallo Perin P, Del Prato S, Frittitta L, Frontoni S, Hribal ML, Marchesini G, Paolisso G, Piatti PM, Solini A, Bonora E; Group of Italian Scientists of Insulin Resistance.

    Diabetes Care. 2007 May;30(5):e33. No abstract available. PMID: 17468362 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.

    Bianchi C, Penno G, Malloggi L, Barontini R, Corfini M, Giovannitti MG, Di Cianni G, Del Prato S, Miccoli R.

    Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):31-8. Epub 2007 Apr 8.PMID: 17420118 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...